Pacira BioSciences faces significant risk as generic challenges threaten Exparel, its flagship product responsible for 78% of 2024 revenue. PCRX's complex formulation, robust patent estate, and ...

The last 12 months have been a bit boring for Novartis AG (NYSE:NVS) and have resulted in a lack of my coverage updates on the company. The stock has delivered a total return of around 18% since my ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...

One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just added semaglutide—the active ingredient in Ozempic and Wegovy—to its list of ...

Medications are rarely made from start to finish in a single country; raw materials, active ingredients and final products often cross multiple borders before reaching patients in the U.S., The New ...

After weeks of speculation, President Donald Trump announced the administration’s plan for pharma tariffs and appeared to back down on the threat of significant action against the European Union. In a ...

Looking for a steady supply of iron in your survival world? This guide shows you how to build an easy and efficient iron farm in Minecraft 1.20+ for both Java and Bedrock Edition — no mods, no command ...

Teva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the Zacks Consensus Estimate of 63 cents. Adjusted earnings rose 8% year over year, ...